Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InflaRx (IFRX) EPS (Weighted Average and Diluted) (2024 - 2025)

Historic EPS (Weighted Average and Diluted) for InflaRx (IFRX) over the last 2 years, with Q2 2025 value amounting to -$35406.9.

  • InflaRx's EPS (Weighted Average and Diluted) rose 259.24% to -$35406.9 in Q2 2025 from the same period last year, while for Jun 2025 it was -$35406.9, marking a year-over-year increase of 259.24%. This contributed to the annual value of -$0.84 for FY2024, which is 59.47% down from last year.
  • Per InflaRx's latest filing, its EPS (Weighted Average and Diluted) stood at -$35406.9 for Q2 2025, which was up 259.24% from -$36349.2 recorded in Q2 2024.
  • In the past 5 years, InflaRx's EPS (Weighted Average and Diluted) registered a high of -$35406.9 during Q2 2025, and its lowest value of -$36349.2 during Q2 2024.